MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31, 2017.

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31, 2017. (CDN$) 3 months to December 31, 2017 3 months to September 30, 2017 Change Dispe...
Read More

MPX APPOINTS NEW CHIEF FINANCIAL OFFICER

TORONTO, ONTARIO, January 16, 2018 – MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial Officer, effective January 15, 2018, subject to regulatory approval. Mr. McLaren br...
Read More